MS Briefs

Dental amalgam fillings show no association with MS


 

Key clinical point: Mercury-containing dental amalgam fillings (AMF) are not associated with the risk of developing multiple sclerosis (MS).

Major finding: The risk of MS with AMF did not differ significantly between patients and control participants (adjusted odds ratio [aOR], 0.823; 95% confidence interval [CI], 0.648-1.046). MS was not associated with AMF irrespective of gender (women: aOR, 0.743; 95% CI, 0.552-1.000; men: aOR, 1.006; 95% CI, 0.670-1.509).

Study details: The data come from a Taiwanese population-based case-control study of 612 participants with MS and 612 matched participants without MS.

Disclosures: No study sponsor was identified. The authors declared no conflicts of interest.

Citation: Tseng CF et al. Int J Environ Res Public Health. 2020 Apr 12. doi: 10.3390/ijerph17082637.

Recommended Reading

Function in MS may vary significantly within EDSS scores
ICYMI Multiple Sclerosis
Cannabis misconceptions still common among MS clinicians
ICYMI Multiple Sclerosis
FDA approves Uplizna for treatment of anti-AQP4 antibody–positive NMOSD
ICYMI Multiple Sclerosis
Relapsing, progressive MS classifications should be abandoned
ICYMI Multiple Sclerosis
CMSC MRI guidelines evolve into international consensus protocol
ICYMI Multiple Sclerosis
MS: Correlation between muscle strength and walking performance
ICYMI Multiple Sclerosis
Relapsing-remitting MS: Relapse rates with oral therapies
ICYMI Multiple Sclerosis
MS tied to higher risk of vascular disease and mortality
ICYMI Multiple Sclerosis
Rituximab safe and effective in pregnant women with MS
ICYMI Multiple Sclerosis
Influenza vaccine efficacy called undiminished in MS
ICYMI Multiple Sclerosis